Search for other papers by Luciana Puleo in
Google Scholar
PubMed
Search for other papers by Laura Agate in
Google Scholar
PubMed
Search for other papers by Irene Bargellini in
Google Scholar
PubMed
Search for other papers by Giuseppe Boni in
Google Scholar
PubMed
Search for other papers by Paolo Piaggi in
Google Scholar
PubMed
Search for other papers by Claudio Traino in
Google Scholar
PubMed
Search for other papers by Tommaso Depalo in
Google Scholar
PubMed
Search for other papers by Giulia Lorenzoni in
Google Scholar
PubMed
Search for other papers by Francesca Bianchi in
Google Scholar
PubMed
Search for other papers by Duccio Volterrani in
Google Scholar
PubMed
Search for other papers by Sandra Brogioni in
Google Scholar
PubMed
Search for other papers by Valeria Bottici in
Google Scholar
PubMed
Search for other papers by Maurizia Rossana Brunetto in
Google Scholar
PubMed
Search for other papers by Barbara Coco in
Google Scholar
PubMed
Search for other papers by Eleonora Molinaro in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
, lungs, bone and more rarely to the skin and brain. Liver metastases occur in 45% of patients with advanced metastatic MTC, and when increasing either in number and/or in size, treatment is indicated ( 5 ). When surgical resection of liver metastases is
Search for other papers by M. Schlumberger in
Google Scholar
PubMed
Search for other papers by L. Bastholt in
Google Scholar
PubMed
Search for other papers by H. Dralle in
Google Scholar
PubMed
Search for other papers by B. Jarzab in
Google Scholar
PubMed
Search for other papers by F. Pacini in
Google Scholar
PubMed
Search for other papers by J.W.A. Smit in
Google Scholar
PubMed
preferably contrast-enhanced MRI of the liver (because liver metastases may be difficult to visualize with CT scan during treatment with antiangiogenic agents), bone scintigraphy and contrast-enhanced MRI of the spine and pelvis [ 6 ]. Fluorodeoxyglucose (FDG
Search for other papers by Marine Sitbon in
Google Scholar
PubMed
Search for other papers by Porhuoy Chou in
Google Scholar
PubMed
Search for other papers by Seydou Bengaly in
Google Scholar
PubMed
Search for other papers by Brigitte Poirot in
Google Scholar
PubMed
Search for other papers by Marie Laloi-Michelin in
Google Scholar
PubMed
Search for other papers by Laure Deville in
Google Scholar
PubMed
Search for other papers by Atanas Pachev in
Google Scholar
PubMed
Search for other papers by Ahouefa Kowo-Bille in
Google Scholar
PubMed
Search for other papers by Clement Dumont in
Google Scholar
PubMed
Search for other papers by Cécile N Chougnet in
Google Scholar
PubMed
dissection. Cervical recurrences were treated by two supplementary surgeries. Liver metastases, which were slowly progressing since 2008, were treated by radiofrequency ablation in 2015. Bone metastases, which were diagnosed in 2010, were treated by external
Search for other papers by Ségolène Hescot in
Google Scholar
PubMed
Search for other papers by Julien Masliah-Planchon in
Google Scholar
PubMed
Search for other papers by Pauline du Rusquec in
Google Scholar
PubMed
Search for other papers by Célia Dupain in
Google Scholar
PubMed
Search for other papers by Maud Kamal in
Google Scholar
PubMed
Search for other papers by Vincent Servois in
Google Scholar
PubMed
Search for other papers by Ivan Bieche in
Google Scholar
PubMed
MTC who harbored two somatic variants of unknown significance (VUS) in the RET gene and responded to pralsetinib. A 48-year-old male with no previous medical history was referred to our center for liver metastases discovered during cholecystectomy
Division of Interventional Radiology, European Institute of Oncology, IRCCS, Milan, Italy
Search for other papers by Giovanni Mauri in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Search for other papers by Steven Bandula in
Google Scholar
PubMed
Search for other papers by Roberto Luigi Cazzato in
Google Scholar
PubMed
Search for other papers by Agnieszka Czarniecka in
Google Scholar
PubMed
Search for other papers by Oliver Dudeck in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Gilles Russ in
Google Scholar
PubMed
Search for other papers by Göran Wallin in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
, 87 ]. Liver Metastases There is considerable experience with TA of liver lesions, including metastases from different tumors [ 88 , 89 ]. After RFA in 512 colorectal liver metastases, local tumor progression-free and overall survival were 72
Search for other papers by Vittoria Guarda in
Google Scholar
PubMed
Search for other papers by Anja Pickhard in
Google Scholar
PubMed
Search for other papers by Melanie Boxberg in
Google Scholar
PubMed
Search for other papers by Katja Specht in
Google Scholar
PubMed
Search for other papers by Anna Maria Stefanie Buchberger in
Google Scholar
PubMed
affected in the reported cases. Distant metastases were more common in the lungs, consistent with results reported for other primary thyroid sarcomas [ 18 ]; skin, bone and liver metastases were also detected. The ultrasound findings mentioned in the case
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Renata Alencar in
Google Scholar
PubMed
Search for other papers by Daniel Barretto Kendler in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade in
Google Scholar
PubMed
Search for other papers by Carla Nava in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Cencita Cordeiro de Noronha Pessoa in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Endocrinology Service, Department of Medicine, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
a higher mortality rate than the control group which had a normal level of this marker (68.7 vs. 23.8%, respectively, p = 0.0004). In addition, they found an association between serum CA19-9 levels and the presence of bone and liver metastases, and
UMR9019, Genome Integrity and Cancers, CNRS, Villejuif, France
Search for other papers by Camille Buffet in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Françoise Kraeber-Bodéré in
Google Scholar
PubMed
CHU Nantes/ICO, Saint-Herblain, France
Search for other papers by Caroline Bodet-Milin in
Google Scholar
PubMed
Université de Paris, Paris, France
Search for other papers by Laure Cabanes in
Google Scholar
PubMed
Department of Radiology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Anthony Dohan in
Google Scholar
PubMed
Search for other papers by Pascal Leprince in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Oncology, Gustave Roussy Institute, Villejuif, France
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Department of Medical Oncology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Olivier Huillard in
Google Scholar
PubMed
Université de Paris, Paris, France
Department of Endocrinology, AP-HP, Hôpital Cochin, Paris, France
Search for other papers by Lionel Groussin in
Google Scholar
PubMed
/mL and 14.5 ng/mL, respectively). A chest CT showed micronodular lung and liver metastases and a suspicious 65-mm myocardial mass in the right atrioventricular groove invading the pericardium, the ipsilateral atrial and ventricular cavities, and the
Search for other papers by Marta Di Stefano in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Carla Colombo in
Google Scholar
PubMed
Search for other papers by Simone De Leo in
Google Scholar
PubMed
Search for other papers by Michela Perrino in
Google Scholar
PubMed
Search for other papers by Mauro Viganò in
Google Scholar
PubMed
Department of Clinical Sciences and Community Health, Milan, Italy
Search for other papers by Luca Persani in
Google Scholar
PubMed
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
symptoms, further imaging was performed by contrast-enhanced CT and/or US, which were repeated during the follow-up for the evaluation of the radiological course. None of these patients had a diagnosis of liver metastases neither before starting LEN therapy
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
also be applied in other human tumours including advanced TC. This procedure seems to have a clinical benefit when liver metastases are smaller than 3 cm and liver involvement is less than 30%. It is yet unproven if conventional TACE used in selected